Orange Book product · Generic (ANDA)
PEMETREXED DISODIUM
PEMETREXED DISODIUM
At a glance
May 25, 2022
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 25, 2022
4 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
PEMETREXED DISODIUM
Strength
EQ 750MG BASE/VIAL
Dosage form
POWDER
Route
INTRAVENOUS
TE code
AP
Application
ANDA 209851
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PEMETREXED DISODIUM
- 2023PEMETREXEDBrand (NDA)
NDA 215179 · SHILPA
- 2022PEMETREXED DISODIUMBrand (NDA)
NDA 214408 · ACCORD HLTHCARE
- 2022PEMETREXED DISODIUMBrand (NDA)
NDA 214218 · HOSPIRA
- 2022PEMETREXED DISODIUMBrand (NDA)
NDA 214657 · SANDOZ
- 2007ALIMTABrand (NDA)
NDA 021462 · LILLY
- 2024PEMETREXED DISODIUMGeneric (ANDA)
ANDA 215460 · HETERO LABS LTD VI
- 2023PEMETREXED DISODIUMGeneric (ANDA)
ANDA 216582 · PRINSTON INC
- 2023PEMETREXED DISODIUMGeneric (ANDA)
ANDA 210047 · AMNEAL
- 2023PEMETREXED DISODIUMGeneric (ANDA)
ANDA 203628 · PHARMOBEDIENT
- 2022PEMETREXED DISODIUMGeneric (ANDA)
ANDA 215479 · MEITHEAL
- 2022PEMETREXED DISODIUMGeneric (ANDA)
ANDA 214436 · BAXTER HLTHCARE CORP
- 2022PEMETREXED DISODIUMGeneric (ANDA)
ANDA 203485 · ACCORD HLTHCARE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
